(S)-4-Benzyl-2-(pyridin-2-ylmethyl)-4,5-dihydrooxazole, 97%, 1g

4,5-Dibromo-2-isopropyl-1H-imidazole, 250mg

tert-Butyl 1-(2-cyanobenzoyl)piperidin-4-ylcarbamate, 95.0%, 1g

tert-Butyl (3aS,9bR)-1,3,3a,4,5,9b-hexahydro-2H-pyrrolo[3,4-c]quinoline-2-carboxylate, 95+%, 100mg

(S)-Octahydropyrrolo[1,2-a]pyrazinedihydrochloride, 95.0%, 5g

2-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 95%, 100mg

5-Methylfuro[3,2-b]pyridine-2-carboxylic acid hydrochloride, 95.0%, 1g

8-(4-Chlorophenyl)-1,4-dioxaspiro[4.5]decane, 95+%, 250mg

7-Bromo-1-chloronaphthalene, 97%, 100mg

Zernike phase contrast kit with E-Plan phase EPLPHi 10/20/S40/S100 oil immersion IOS objectives, rotating Zernike condenser, telescope and green filter

Bis(4-methoxyphenyl)amine, 95.0%, 100g

2-Fluoro-5-(trifluoromethyl)phenylisothiocyanate, 97.0%, 1g

Acetic acid 100%, Ph. Eur., pure, 1 l, glass packaging